223 related articles for article (PubMed ID: 26554929)
41. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines.
Paluchowska MH; Bugno R; Duszyńska B; Tatarczyńska E; Nikiforuk A; Lenda T; Chojnacka-Wójcik E
Bioorg Med Chem; 2007 Nov; 15(22):7116-25. PubMed ID: 17825569
[TBL] [Abstract][Full Text] [Related]
42. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
43. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
44. Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyl-diphenyl diselenide in mice.
Brüning CA; Prigol M; Roehrs JA; Nogueira CW; Zeni G
Behav Brain Res; 2009 Dec; 205(2):511-7. PubMed ID: 19683021
[TBL] [Abstract][Full Text] [Related]
45. Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors.
Zhu H; Huang Q; Xu H; Niu L; Zhou JN
Behav Brain Res; 2009 Jan; 196(2):200-6. PubMed ID: 18817816
[TBL] [Abstract][Full Text] [Related]
46. Effects of 5-HT
Maxwell J; Gleason SD; Falcone J; Svensson K; Balcer OM; Li X; Witkin JM
Behav Brain Res; 2019 Feb; 359():467-473. PubMed ID: 30471311
[TBL] [Abstract][Full Text] [Related]
47. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
Kasahara K; Hashimoto S; Hattori T; Kawasaki K; Tsujita R; Nakazono O; Takao K; Kawakubo H; Nagatani T
J Pharmacol Sci; 2015 Jan; 127(1):109-16. PubMed ID: 25704026
[TBL] [Abstract][Full Text] [Related]
48. Anxiolytic and antidepressant activities of Pelargonium roseum essential oil on Swiss albino mice: Possible involvement of serotonergic transmission.
Abouhosseini Tabari M; Hajizadeh Moghaddam A; Maggi F; Benelli G
Phytother Res; 2018 Jun; 32(6):1014-1022. PubMed ID: 29468757
[TBL] [Abstract][Full Text] [Related]
49. The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling.
Sałaciak K; Głuch-Lutwin M; Siwek A; Szafarz M; Kazek G; Bednarski M; Nowiński L; Mitchell E; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Kołaczkowski M; Szkaradek N; Marona H; Sapa J; Pytka K
J Psychopharmacol; 2020 Dec; 34(12):1431-1442. PubMed ID: 33103555
[TBL] [Abstract][Full Text] [Related]
50. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
51. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
Ishibashi T; Horisawa T; Tokuda K; Ishiyama T; Ogasa M; Tagashira R; Matsumoto K; Nishikawa H; Ueda Y; Toma S; Oki H; Tanno N; Saji I; Ito A; Ohno Y; Nakamura M
J Pharmacol Exp Ther; 2010 Jul; 334(1):171-81. PubMed ID: 20404009
[TBL] [Abstract][Full Text] [Related]
52. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test.
Estrada-Camarena E; Fernández-Guasti A; López-Rubalcava C
Neuropsychopharmacology; 2006 Feb; 31(2):247-55. PubMed ID: 16012533
[TBL] [Abstract][Full Text] [Related]
53. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
Vicente MA; Zangrossi H
Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
[TBL] [Abstract][Full Text] [Related]
54. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
[TBL] [Abstract][Full Text] [Related]
55. Involvement of GABAergic system in regulation of the anxiolytic- and antidepressant-like effects of Scrophularia striata extract in rats.
Kosari-Nasab M; Babri S; Fatehi-Gharehlar L; Doosti MH; Pakzad S
Pharm Biol; 2013 May; 51(5):581-8. PubMed ID: 23373710
[TBL] [Abstract][Full Text] [Related]
56. Anxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABAA/benzodiazepine neurotransmission.
Chioca LR; Ferro MM; Baretta IP; Oliveira SM; Silva CR; Ferreira J; Losso EM; Andreatini R
J Ethnopharmacol; 2013 May; 147(2):412-8. PubMed ID: 23524167
[TBL] [Abstract][Full Text] [Related]
57. SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity.
Depoortere R; Boulay D; Perrault G; Bergis O; Decobert M; Françon D; Jung M; Simiand J; Soubrié P; Scatton B
Neuropsychopharmacology; 2003 Nov; 28(11):1889-902. PubMed ID: 12902993
[TBL] [Abstract][Full Text] [Related]
58. Potentials of Mangifera indica in the treatment of depressive-anxiety disorders: possible mechanisms of action.
Ishola IO; Awodele O; Eluogu CO
J Complement Integr Med; 2016 Sep; 13(3):275-287. PubMed ID: 27276531
[TBL] [Abstract][Full Text] [Related]
59. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
[TBL] [Abstract][Full Text] [Related]
60. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
